Lars Sjödin, Sarah Marklund, Claudia Lampic, Lena Wettergren
{"title":"Anxiety and Depression Trajectories in Young Adults Up to 5 Years After Being Diagnosed With Cancer","authors":"Lars Sjödin, Sarah Marklund, Claudia Lampic, Lena Wettergren","doi":"10.1002/cam4.70715","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>This study aimed to identify and characterize trajectories of anxiety and depression symptoms in a national cohort of young women and men up to 5 years after being diagnosed with cancer. Furthermore, potential sociodemographic, clinical, and psychosocial factors predictive of different trajectory groups were examined.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A population-based sample of 1010 young adults aged 18–39 at diagnosis with selected cancers/tumors (brain/breast/cervical/lymphoma/ovarian/testicular) completed a survey 1.5 years, 3 years (T2, <i>n</i> = 722) and 5 years (T3, <i>n</i> = 659) post-diagnosis. Responses to the Hospital Anxiety and Depression Scale were computed using five trajectories as outcome groups: <i>Stable cases</i>, <i>Stable non-cases</i>, <i>Improving</i>, <i>Worsening</i>, and <i>Fluctuating</i>. Multinomial logistic regression models were performed to identify predictive factors of different trajectories.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The most common trajectories for anxiety symptoms were Stable non-cases (36%) and Stable cases (26%), followed by Improving (17%), Fluctuating (11%), and Worsening (10%). In contrast, the dominant trajectory for depression symptoms was Stable non-cases (69%), with smaller groups identified as Improving (10%), Worsening (8%), Stable cases (7%), and Fluctuating (6%). Factors associated with several unfavorable trajectories were female sex, pre-diagnosis support for emotional issues, fatigue, and financial problems (<i>p</i> < 0.05).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Symptoms of anxiety and depression follow five different developmental paths among young people with cancer. Within the first 5 years after a cancer diagnosis, a majority of young adults meet clinical levels of anxiety (64%) and a third meet clinical levels of depression (31%). It is important to consider risk factors for mental illness in the follow-up care of people with cancer.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 5","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70715","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70715","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aims
This study aimed to identify and characterize trajectories of anxiety and depression symptoms in a national cohort of young women and men up to 5 years after being diagnosed with cancer. Furthermore, potential sociodemographic, clinical, and psychosocial factors predictive of different trajectory groups were examined.
Methods
A population-based sample of 1010 young adults aged 18–39 at diagnosis with selected cancers/tumors (brain/breast/cervical/lymphoma/ovarian/testicular) completed a survey 1.5 years, 3 years (T2, n = 722) and 5 years (T3, n = 659) post-diagnosis. Responses to the Hospital Anxiety and Depression Scale were computed using five trajectories as outcome groups: Stable cases, Stable non-cases, Improving, Worsening, and Fluctuating. Multinomial logistic regression models were performed to identify predictive factors of different trajectories.
Results
The most common trajectories for anxiety symptoms were Stable non-cases (36%) and Stable cases (26%), followed by Improving (17%), Fluctuating (11%), and Worsening (10%). In contrast, the dominant trajectory for depression symptoms was Stable non-cases (69%), with smaller groups identified as Improving (10%), Worsening (8%), Stable cases (7%), and Fluctuating (6%). Factors associated with several unfavorable trajectories were female sex, pre-diagnosis support for emotional issues, fatigue, and financial problems (p < 0.05).
Conclusion
Symptoms of anxiety and depression follow five different developmental paths among young people with cancer. Within the first 5 years after a cancer diagnosis, a majority of young adults meet clinical levels of anxiety (64%) and a third meet clinical levels of depression (31%). It is important to consider risk factors for mental illness in the follow-up care of people with cancer.
目的:本研究旨在识别和描述被诊断为癌症的年轻女性和男性长达5年后的焦虑和抑郁症状的轨迹。此外,潜在的社会人口学,临床和社会心理因素预测不同的轨迹组进行了检查。方法以人群为基础的1010名年龄在18-39岁之间的诊断为特定癌症/肿瘤(脑/乳腺/宫颈/淋巴瘤/卵巢/睾丸)的年轻人,在诊断后1.5年、3年(T2, n = 722)和5年(T3, n = 659)完成调查。对医院焦虑和抑郁量表的反应使用五个轨迹作为结果组来计算:稳定病例、稳定非病例、改善、恶化和波动。采用多项逻辑回归模型来识别不同轨迹的预测因素。结果焦虑症状最常见的轨迹是稳定(36%)和稳定(26%),其次是改善(17%)、波动(11%)和恶化(10%)。相比之下,抑郁症状的主要轨迹是稳定的非病例(69%),较小的组确定为改善(10%),恶化(8%),稳定(7%)和波动(6%)。与一些不利轨迹相关的因素是女性、对情绪问题的诊断前支持、疲劳和经济问题(p < 0.05)。结论青少年癌症患者的焦虑和抑郁症状有五种不同的发展路径。在癌症诊断后的前5年内,大多数年轻人达到临床水平的焦虑(64%),三分之一达到临床水平的抑郁(31%)。在癌症患者的后续护理中,考虑精神疾病的危险因素是很重要的。
期刊介绍:
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:
Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations
Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.
Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.
Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.
Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.